These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32579985)

  • 1. Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients.
    M MB; L B; I A; P D; E I; F C; M LV; J M; M FR; M U; G H
    J Infect; 2020 Sep; 81(3):452-482. PubMed ID: 32579985
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):127. PubMed ID: 32468178
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Loscocco GG
    Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexamethasone: A boon for critically ill COVID-19 patients?
    Patel SK; Saikumar G; Rana J; Dhama J; Yatoo MI; Tiwari R; Rodríguez-Morales AJ; Dhama K
    Travel Med Infect Dis; 2020; 37():101844. PubMed ID: 32791213
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study.
    Abou-Arab O; Huette P; Debouvries F; Dupont H; Jounieaux V; Mahjoub Y
    Crit Care; 2020 Nov; 24(1):645. PubMed ID: 33183348
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.
    Painvin B; Guillot P; Verdier MC; Gacouin A; Maamar A
    Intensive Care Med; 2020 Sep; 46(9):1772-1773. PubMed ID: 32514594
    [No Abstract]   [Full Text] [Related]  

  • 8. Etoposide-based therapy for severe forms of COVID-19.
    Hamizi K; Aouidane S; Belaaloui G
    Med Hypotheses; 2020 Sep; 142():109826. PubMed ID: 32416415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
    Nahum J; Morichau-Beauchant T; Daviaud F; Echegut P; Fichet J; Maillet JM; Thierry S
    JAMA Netw Open; 2020 May; 3(5):e2010478. PubMed ID: 32469410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.
    Miao Y; Fan L; Li JY
    Front Immunol; 2020; 11():1445. PubMed ID: 32612616
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study.
    Mukhtar A; Lotfy A; Hasanin A; El-Hefnawy I; El Adawy A
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):579-580. PubMed ID: 32736030
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very severe COVID-19 in the critically ill in Tunisia.
    Saida IB; Ennouri E; Nachi R; Meddeb K; Mahmoud J; Thabet N; Jerbi S; Boussarsar M
    Pan Afr Med J; 2020; 35(Suppl 2):136. PubMed ID: 33193951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
    Jiménez-Brítez G; Ruiz P; Soler X
    Med Clin (Barc); 2020 Nov; 155(9):410-411. PubMed ID: 32718713
    [No Abstract]   [Full Text] [Related]  

  • 15. How likely are COVID-19 interventions to benefit the sickest patients?
    Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
    Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19).
    Schoergenhofer C; Jilma B; Stimpfl T; Karolyi M; Zoufaly A
    Ann Intern Med; 2020 Oct; 173(8):670-672. PubMed ID: 32422065
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
    Taccone FS; Gorham J; Vincent JL
    Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19.
    Irie K; Nakagawa A; Fujita H; Tamura R; Eto M; Ikesue H; Muroi N; Tomii K; Hashida T
    Clin Transl Sci; 2020 Sep; 13(5):880-885. PubMed ID: 32475019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections in critically ill patients with COVID-19.
    Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M
    Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
    Martinez Navarro W; Ly L; Segal MS; Shukla AM
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.